Technische Universität München (TUM)

Integration of Molecular Communications into Future Generation Wireless Networks (2019) Haselmayr W, Springer A, Fischer G, Alexiou C, Boche H, Höher PA, Dressler F, Schober R Conference contribution, Abstract of lecture Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer (2019) Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, et al. Journal article Update Breast Cancer 2019 Part 2-Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice (2019) Janni W, Schneeweiss A, Mueller V, Woeckel A, Lux MP, Hartkopf AD, Nabieva N, et al. Journal article, Review article Update Breast Cancer 2019 Part 1-Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer (2019) Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Nabieva N, Taran FA, et al. Journal article, Review article Bioinspired multifunctional layered magnetic hybrid materials (2019) Debus C, Wu B, Kollmann T, Duchstein P, Siglreitmeier M, Herrera S, Benke D, et al. Journal article Addiction in IBD patients: more than just smoke? (2019) Hirschmann S, Koehnen J, Schuster B, Atreya R, Krauss N, Mudter J, Dauer M, et al. Conference contribution Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis (2019) Klompmaker S, Peters NA, Van Hilst J, Bassi C, Boggi U, Busch OR, Niesen W, et al. Journal article Mutated Rnf43 aggravates Helicobacter pylori-induced gastric pathology (2019) Neumeyer V, Vieth M, Gerhard M, Mejías-Luque R Journal article HyTeG: A High Performance Multigrid Framework on Hybrid Meshes (2019) Thönnes D, Kohl N, Drzisga D, Bartuschat D, Rüde U Conference contribution, Conference Contribution Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article